Doxazosin
- Product NDC
- 50090-6401
- 11-digit product format
- 500906401
- Labeler code
- 50090
- Product ID
- 50090-6401_720e22d0-a728-4f14-b60b-0bc963be56f4
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Doxazosin Mesylate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- A-S Medication Solutions
- Application
- ANDA075536
- Marketing category
- ANDA
- Marketing start
- 2014-08-06
- Substance
- DOXAZOSIN MESYLATE
- Active strength
- 2 mg/1
- Pharmacologic classes
- Adrenergic alpha-Antagonists [MoA], alpha-Adrenergic Blocker [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Doxazosin
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| DOXAZOSIN MESYLATE | 2 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 86P6PQK0MU |
| Rxcui | 197626 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50090-6401-0 | Doxazosin | 30 in 1 BOTTLE | TABLET | 30 | | 12 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50090-6401 | DOXAZOSIN (DOXAZOSIN MESYLATE) TABLET [A-S MEDICATION SOLUTIONS] | 10 | Current NDC, 1 package rows | 20230913_57f4a953-ad23-4a44-9956-c48aa5927132.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 50090-6401-0 | 50090640100 | 30 TABLET in 1 BOTTLE (50090-6401-0) | 30 tablet | 2023-03-20 | No | No | Historical |